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Co-workers and I examined the early events in the 
interaction of rat peritoneal mast cells with a number of 
noncytotoxic mast cell stimuli. These studies demon-
strated that an interaction limited to the cytoplasmic 
membrane is sufficient to induce a secretory mast cell 
response. Additional experiments suggested that a con-
tinued interaction between the stimulus and the mem-
brane receptor is required for maintenance of the secre-
tory response. We have provided evidence to support the 
concept that different mast cell activators interact with 
different receptors on the cell membrane and initiate 
distinct biochemical pathways leading to secretion. Fi-
nally, we have shown that pretreatment of mast cells 
with concentrations of a stimulus that, by themselves, 
are incapable of initiating a secretory response can pro-
foundly affect the ability of mast cells to respond fully to 
a subsequent challenge with an optional concentration 
of stimulus. 
The interaction of a number of diverse stimuli with mast cells 
initiates a cascading chain of biochemical events that eventually 
results in degranulation and release of granule-localized vaso-
active amines. Important among these mast cell activators, 
from an immunopathological point of view, are antigen inter-
acting with cell-bound IgE antibody, the complement-derived 
anaphylatoxin polypeptides (C3a and C5a), and one or more 
cationic proteins contained within the lysosomal granules of 
polymorphonuclear leukocytes [1]. All of these molecules have 
been demonstrated to initiate noncytotoxic mast cell secretion, 
and their contribution to the host inflammatory response lead-
ing to tissue injury has been well documented. 
In an effort to understand better the molecular mechanisms 
that characterize the events occurring during the secretory 
response of mast cells to noncytotoxic stimuli, many investiga-
tors have adopted, as a model system, the secretory response of 
rat peritoneal mast cells. One can obtain relatively lal'ge num-
bers of pure suspensions of mast cells from this system, and 
several activators, in addition to those described above, have 
been characterized [1]. These molecules include polymyxin B 
sulfate, Compound 48/80, dextran, ATP, the calcium ionophore 
A23187, and a low-molecular-weight cationic protein we have 
recently isolated from cobra venom (CV A protein) [2]. As will 
be demonstrated below, there are several advantages to using 
t his latter mast cell activator in studying the mechanisms of 
mast cell secretion. 
The results of studies by other investigators have provided 
considerable information on many of the biochemical events 
that regulate mast cell secretion and degranulation [reviewed 
in reference 3]. It seems clear that the mast cell secretory 
response (as is true for a variety of inflammatory cell responses) 
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requires cellular energy and the inhibitors of oxidative phos-
phorylation and glycolysis inhibit amine release. The presence 
of calcium is obligatory, and in most systems secretion appeal's 
to be regulated by cyclic nucleotides. There is evidence for the 
activation of a precursor protease as an eal'ly step in the 
biochemical sequence leading to secretion, and there also is 
some evidence for assembly of microtubules and/ or microflla-
ments as more terminal events in the degranulation process. 
The experiments described in this paper focus on the eal'ly 
steps in the chain of events that leads to mast cell secretion 
and degranulation, including the initial interaction between 
noncytotoxic stimuli and the mast cells. I will examine: whether 
a stimulus-cell interaction is necessary or sufficient for a secre-
tory response; the utilization of a common or distinct biochem-
ical pathway by different mast cell stimuli; and the results of 
experiments defining the events that occur after the initial 
stimulus-cell interaction. 
Unpurified suspensions of mast cell were obtained by peri~ 
toneallavage of 300- to 350-gm male Wistar rats (Chal'les River, 
Boston, Mass.) essentially as previously described [4]. The cells 
were labeled with 3H-serotonin (2.2 Ci/mmole, New England 
Nuclear, Boston, Mass.) and maintained in plastic tubes in tris-
Tyrodes buffer supplemented with 0.05% ovalbumin (Sigma 
Chemical, St. Louis, Mo.) at room temperature until used in 
the experiments. 
As we have previously demonstrated, the release of exoge-
nously supplied radiolabeled serotonin parallels that of endog-
enous histamine, and serves as a convenient measure of mast 
cell secretion [4]. All experiments were carried out at 37°C in 
plastic tubes. After incubat ion, cells were centrifuged at 1,000 
Xg for 5 min, and aliquots of supernatants were assayed for 
released 3H-serotonin, which was measured in a liquid scintil-
lation spectrometer. 
Compound 48/80 (Sigma Chemical) was radiolabeled with 
NaJ31 I (carrier-free, Cambridge Nuclear, Boston, Mass.) as pre-
viously described [4]. Polymyxin B sulfate (Sigma Chemical) 
was covalently linked to desulfated, epichlorohydrin cross-
linked Sephal'ose 4B (Pharmacia, Rahway, N.J.) by previously 
published methods [5]. The anaphylatoxin C3a was prepared 
by limited trypsin digestion of purified human C3 [6]. The 
mast-ceIl-activating protein from cobra venom (CV A protein) 
was purified from the venom of Naja naja (Ross Snake Farm, 
Silver Springs, Fla.) by means of procedures already described 
[2]. 
For electron microscopic studies mast cells were fixed for 5 
min at 37°C with 2% glutarlildehyde in 0.1 M cacodylate buffer 
(pH 7.2), centrifuged, and fixed for 2 hr as above at 4°C. ,After 
they were washed with buffer, they were postfixed with 1 % 
OS04 in 0.1 Ms-collidine buffer (pH 7.2) at 4°C for 1 hr, washed 
again, stained en bloc with uranyl acetate (0.25% in H20), 
embedded in 2% agar, dehydrated in alcohol, embedded in 
epon, sectioned, and stained with 2% aqueous uranyl acetate 
and lead citrate. 
DEMONSTRATION OF CELL MEMBRANE 
ACTIVATION 
Although it seems the initiation of mast cell secretion by 
antigen most probably involves an interaction with cell-mem-
brane-Iocalized IgE antibody [for review, see reference 7], the 
existence of such a mechanism is less certain in the case of the 
low-moleculal'-weight stimuli, such as Compound 48/ 80, for 
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internalization of these stimuli could occur prior to secretion. 
Therefore, if we are to postulate that such stimuli can serve as 
useful models in the study of mast cell secretion, we must 
demonstrate that stimulation of the mast cell cytoplasmic mem-
brane is sufficient to initiate secretion and degranulation. 
To do this, we took advantage of the fact that polymyxin B 
sulfate, a low-molecular-weight noncytotoxic mast cell stimulus, 
contains several reactive primary amines that facilitate their 
covalent attachment to a succinylated insolubilized Sepharose 
4B carrier; we utilized such an insolubilized Sepharose 4B-
polymyxin B to examine whether interaction at the mast cell 
membrane is sufficient to initiate secretion and mast cell de-
granulation [5]. 
As shown in Table I, the addition of insolubilized Sepharose 
4B-polymyxin B to suspensions of mast cells initiated dose-
dependent secretion of oR-serotonin. No release was observed 
with control Sepharose 4B. A further factor controlling poten-
tial contamination by unbound polymyxin B was the fact that 
supernatants from insolubilized activator, incubated in the ab-
sence of and subsequently added to mast cells, were also incap-
able of initiating secretion. (We took stringent precautions to 
rule out contaminating soluble activator in these experiments 
[5]). 
When these suspensions were examined microscopically, vir-
tually all of the mast cells were bound to the Sepharose 4B 
treated with polymyxin B (Fig 1). We saw no interaction with 
control preparations of Sepharose 4B. In addition, the bound 
mast cells ~ere extensively degranulated. Thus, these experi-
ments strongly suggest that a stimulus-cell interaction that is 
limited to the cytoplasmic membrane is sufficient to initiate a 
secretory mast cell response. 
REQUIREMENT FOR CONTINUED STIMULUS-MAST 
CELL INTERACTION 
Although an initial interaction between the stimulus and its 
receptor on the mast cell cytoplasmic membrane is necessary 
for the initiation of a secretory resp'onse, the need for a contin-
ued interaction between the mast cell and the stimulus once 
secretion has been initiated is not so certain. To eliminate or 
confIrm this possibility, we made use of 2 observations. The 
fIrst (Fig 2) is that the secretion of serotonin from mast cells 
initiated by CV A protein (and C3a anaphylatoxin) occurs over 
a relatively extended period of time, in contrast to the secretory 
response initiated by activators such as Compound 48/80 or 
polymyxin B; with either of the latter 2 compounds, the secre-
tory response is complete within 1 min. The second observation 
(Fig 3) is that over a wide range of mast cell concentrations, the 
rate of secretion initiated by CV A protein is independent of the 
concentration of mast cells and is thus dependent only on the 
binding affinity of the CV A protein and the mast cell mem-
brane. 
Making use of these observations we examined the require-
ment for continued stimulus-cell interaction. Thus, secretion 
can be initiated at one mast cell concentration and then dilution 
can be made to a lower cell concentration-one that would 
cause the resulting stimulus concentration to be below the 
TABLE 1. Initiation of secretion from mast cells by Sepharose 4B-
polymyxin B 
Release (%) "H-serotonin with 
Dose Sepharose 4B-poly-Sepharose 4B 
myxin B 
25/-LI" 4.4 6.2 
50 4.3 9.7 
100 4.4 15.5 
150 4.1 22.2 
200 4.0 27.0 
" Volume of packed beads added to mast cells. 
I 
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threshold necessary for the induction of secretion. An analysiS 
of the subsequent secretory response should yield information , 
on the necessity of continuous interaction between the stimulus 
and the mast cells. 
The basic protocol for the experiment, shown in Fig 4, reo 
vealed that at either mast cell concentration (5 X 105 oJ' 5_~ 
104/ml) the higher CVA protein concentration (0.5 /-Lg/ nu 
initiated a time-dependent secretion, whereas the lower conceO' 
tration (0.5 /-L / ml) did not induce secretion. Therefore, whe~ ) 
mast cells were initially incubated at the higher stimulus B.n 
cell concentration and at various times diluted 10-fold wI~h . 
prewarmed buffer, the resultant secretory responses shown I~ 
Fig 5 were obtained. Dilution of the stimulus to a subthreshold 
concentration of CV A protein for initiation of secretion resulte 
in an immediate cessation of the secretory response. TheSe 
results suggest that a continued interaction between the stiJll; 
ulus and the mast cell receptor is necessary for maintenance 0 
the secretory state. 
EVIDENCE FOR DISTINCT MAST CELL RECEPTORS 
There are numerous stimuli that can initiate secretion of 
mast cells. In order to find out whether these all interact at th~ 
same site on the mast cell membrane, we used radiolabe!e 
Compound 48/80 to examine the specificity of the bindln; 
interaction between various activators and peritoneal rIlas , 
cells. Because in our initial experiments the secretory respons1 
of mast cells had exposed numerous new sites for the binding 0 
Compound 48/80, all binding experiments were performed .o~ 
cells that were inhibited from secretion by pretreatment WIt 
2-deoxyglucose and azide [4]. 
Experimentally, we examined the capacity of increasing can; 
centrations of a number of stimuli to inhibit the binding a . 
radiolabeled Compound 48/80 to mast cells. As predicted, un; 
labeled compound 48/80 effectively inhibited the binding .o 
radiolabeled compound 48/80 (Fig 6). Polymyxin B alsO 10; 
. hibited the binding of radiolabeled Compound 48/80, a £8e
o that suggests these 2 molecules compete for the same sites ~ 
the mast cell membrane. In contrast, an approximately 10 '0 
fold molar excess of 2 other mast cell activators, CV A prot/e~O I 
and ATP, gave relatively little inhibition of Compound 48 
binding. 
DEMONSTRATION OF DISTINCT MODES OF MAS'!' 
CELL ACTIVATION 
asl The observed time course of the secretory response of rIl el 
cells to various stimuli (Fig 2) and the binding experiment 0 \ 
described above (Fig 6) suggest that Compound 48/80 ~nll 
polymyxin B sulfate may activate mast cells by a mechanISI,. ' 
distinct from that initiated by CV A protein and C3a anapb) 
1 . I atoxln. . 0 
To further explore this possibility, we utilized the observars 
that mast cells, after exposure to a noncytotoxic stilnU~; 
become unresponsive, or desensitized, to a second exposure.sJ1 ' 
that same stimulus. Thus, if the mast cells could not distingu1 Us 
between 2 stimuli, an initial interaction between the mast ce o. 
and 1 stimulus would result in the mast cells becoming desay 
sitized to a subsequent challenge with the second stimul~s. Ii 
contrast, if the cells could distinguish between the 2 stirIllle: 
exposure to the fIrst stimuli would have no effect on a .subSIS 
quent challenge with a second stimulus. In these experHpe°rl" 
we examined both the initial and the secondary secretOte 
response of mast cells to Compound 48/80, polymyxin B sulf8J~ 
CV A protein, and C3a anaphylatoxin [8]. Representative reSll eli 
of a number of experiments are shown in Tables II-IV. In e8 r I 
case, the initial exposure of mast cells to each of the activat?tJ1 
resulted in an unresponsiveness to secondary challenge w;erl l 
that same stimulus. In addition, mast cells initially stirnU1a J)' 
with polymyxin B were subsequently unresponsive to COilS 
pound 48/80 challenge and vice verse (Table II). Similar resu 
JUly 1978 
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. FIC 1 Phot . -In the t' omIcl'ographs of Sepharose 4B added to peritoneal exudate cells. Cells and preparations of Sepharose 4B were prepared as described 
1000). Ce~ and stained with 0.1 % toluidine blue dye in 20% formalin. A, Sepharose 4B (reduced from x 320). B, Sepharose 4B (reduced from x 
ill Seph' epharose 4B-polymyxin B (reduced from x 320) . D, Sepharose 4B-polymyxin B (reduced from 1,000). The dark, granular stain observed 
margin a~ose-4B-polymyxin-B-bound mast cells in Ie and ID is caused by the binding of toluidine blue to granules being released at the peripheral 
o the mast cells. The dark appearance of the smooth-sUl"faced, free mast cells is caused by the different level of focus. 
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FIG 2. Time course of "H -serotonin from mast cells. Mast cells were 
incubated wit h either compound 48/80 (0.2 Ilg/ml) , polymyxin B (1 
Ilg/ml) , low molecular-weight cationic protein cobra venom (0.5 Ilg/ml) , 
or C3a (20 Ilg/ml) for various lengths of time, after which aliquots were 
removed and assayed for release of "H-serotonin. 
-... 
"" 
Slope =1.02 
Mast Cells/ml 
FIG 3. Rate of secretion of "H-serotonin from mast cells-effect of 
mast cell concentration. Various concentrations of mast cells, in 1.0 ml 
of buffer, were incubated at 37°C with 1.0 Ilg of low molecular-weight 
ca tionic protein cobra venom. At various times, 100-1l1 aliquots were 
removed, put in to 400 III of ice-cold buffer and centrifuged; secretion of 
"H -serotonin was then measured. Ini tial rates of secretion were deter-
mined from the best straight line fi ts to the data over the first 8 min 
and plotted versus t he mast cell concentration. 
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FIG 4. Rates of secretion from mast cells at 2 low molecular-weigh t 
cationic protein cobra venom (CV A) concentrations. a, Higher mast 
cell concentration: Approximately 5 x 10" mast cell/ ml were incubated 
for various times with 0.5 Ilg/ ml or 0.05 Ilg/ml of CV A protein; secretion 
was determined as described in the capt ion of Fig 2. b, Lower mast cell 
concentration: Experimental protocol identical to Fig 4a except that 
mast cell concent ration was 5 X 10' ce lls/m!' 
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FIG 5. Effect of stimulus dilution on mast cell secretion. Mast cells, 
a t a concentration of 5 X 10" mast cell/ ml, were incubated at 37°C with 
0.5 Ilg/ ml of low molecular-weight ca tionic protein cobra venom. At 
various times 100-lll aliquots were removed and diluted in 400 III of ice-
cold buffer. At the t imes indicated, cells (and activator) were diluted 
10-fold with buffer prewarmed at 37°C. Aliquots were then removed 
after addit ional incubation, exactly as described above, and the percent 
secretion was determined. a, 2 min; b, 4 min; C, 8 min; and d, 12 min. 
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FIG 6. Inhibition of binding of Compound 48/80 to mast cells by 
variolls mast ceU activators. Mast ceUs (1.0 x 10") pretreated wi th 2· 
deoxyglucose and azide were incubated for 10 min with 0.5 Ilg of 1311. 
Compound 48/ 80 and increasing amounts of the unlabeled ac tivators 
Compound 48/80, polymyxin B sulfate, low molecular-weight cationir 
protein cobra venom or ATP. Cells were then sedimented by centrifu· 
gation and washed, and then radioactivity bound to the cell was 
determined. 
TABLE II. Desensitization of mast cells by type 1 activators 
2° incubation: release (%) wit.h ll 
10 incubation with Release (%) Compound 
48/80 Polymyx in B Buffer 
Compound 48/80 35.6 5.8 10.4 3.1 
P olymyxin B 48.9 6.7 7.4 5.1 
Buffer 2.1 44.0 61.3 2.1 
" Expressed as a percent of remaining :IH-serotonin. 
were obtained when CV A protein and C3a anaphylatoxin were 
used (Table III). Significantly, mast cells exposed to Compound 
48/ 80, although desensitized to secondary challenge with thi 
stimulus, were still completely responsive to CV A protein; 
similar results were obtained when the order of stimuli wa 
reversed (Table IV) . 
NONIDENTITY OF SECRETION P ATHW A YS 
INITIATED BY DIFFERENT MAST CELL 
ACTIVATORS 
The combined data noted above provide evidence tha t dif-
ferent mast cell stimuli interact with distinct receptors on the 
mast cell cytoplasmic membrane and initiate distinct pathways 
July 1978 RECEPTOR MODULATION AND MAST CELL SECRETION 89 
TA BLE III. Desensitization of mast cells by type 2 activators 
10 inc ubat.ion with Release (%) 
2° incubations: release (%) with" 
CVA protein C3a Buffer 
CVA protein 35.9 5.6 3.4 4.0 
C3a 33.4 6.2 3.9 3.3 
Buffer 4.9 24.6 21.3 1.5 
" Expressed as a percent of remaining "H-sero tonin. 
TABLE IV. Desensitization of mast cells by type 1 an.d type 2 
activators 
20 incubation: release (%) with" 
10 incubation with Release (%) Compound 
48/ 80 CVA protein Buffer 
Compound 48/80 48.9 6.7 20.4 5.1 
CVA protein 27.0 47.7 5.0 5.2 
Buffer 2.1 61.3 29.5 2. 1 
" Expressed as a percent of remaining "H-serotonin. 
leading to secretion and degranulation. We next examined 
whether any of the biochemical steps in the activation sequence 
leading to secretion that occurred after the initial activation 
step were shared by all mast cell stimuli. For these experiments 
we took advantage of our chance observation that a number of 
serum proteins, and particularly serum albumins, selectively 
inhibited the secretion initiated by some mast cell activators 
(9). For example, using the 4 mast cell stimuli described in the 
previous section, we demonstrated that the presence of bovine 
serum albumin (72 IlM) completely inhibits the capacity of both 
CV A protein and C3a anaphylatoxin to initiate mast cell secre-
tion yet has virtually no effect on (in fact, slightly enhances) 
secretion initiated by Compound 48/80 and polymyxin B (Table 
V). This inhibition requires the presence of albumin during the 
activation because pretreatment with significantly higher con-
centrations of albumin in the absence of stimulus (140 IlM) , 
followed 'by washing and subsequent stimulation with CV A 
protein or C3a, has no effect on mast cell secretion. In addition, 
we demonstrated that the inhibition is most probably due to 
the serum albumin molecule itself and not a contaminant in the 
albumin preparation (10). 
In an attempt to further elucidate the mechanism of the 
observed inhibition of C3a- and CVA-initiated secretion, we 
examined the effect of limited exposure of mast cells to CV A 
protein in the presence of inhibitory concentrations of bovine 
serum albumin, followed by a subsequent exposure of mast cells 
to CV A protein in the absence of albumin [10]. The rationale 
behind this experiment was that, if albumin prevented the CV A 
protein from interacting with the mast cells, either by an 
interaction of albumin with CV A protein or by an interaction 
of albumin with the putative receptor on the mast cell mem-
brane to which CV A binds, subsequent removal of the albumin 
would leave the mast cells fully able to respond to subsequent 
exposure to CV A protein. If, on the other hand, albumin in-
hibited the secretory response at a point in the activation 
sequence subsequent to the interaction of CV A protein with its 
receptor, mast cells would become progressively desensitized to 
CV A protein when subsequently challenged in the absence of 
the albumin inhibitor. 
This experiment clearly demonstrated that the latter of the 
2 possibilities suggested above is the correct one (Fig 7) . The 
presence of inhibitory concentrations of bovine serum albumin 
did not prevent mast cells from becoming temporally desensi-
tized to CV A protein, with an approximate half-life of 13 min. 
It appears, then, that the inhibitory effect of albumin is manifest 
at a point in the activation sequence subsequent to the stimulus-
receptor interaction that leads to a state of activation which 
can become desensitized. Because inhibition was not observed 
with all mast cell stimuli (e.g., Compound 48/80 lind polymyxin 
B sulfate), these data suggest that some biochemical step sub-
sequent to the stimulus-cell interaction also is not shared by all 
mast cell activators. 
Although our data clearly demonstrated that the presence of 
serum albumin inhibits the secretion initiated by CV A protein, 
they did not rule out the possibility that mast cell degranulation 
proceeds normally in the presence of albumin, and that only 
the release of serotonin is inhibited. To eliminate or confirm 
this possibility, we morphologically examined the effect of CVA 
protein on mast cells in the presence and absence of inhibitory 
TABLE V. Inhibition of mast cell release by bovine serum albumin 
Release (%), "H-serotonin 
Activato r" 
-BSA" +BSA 
Compound 48/ 80 20.8 23.2 
Polymyxin B 24.6 30.0 
CV A" protein 28.7 4.9 
C3a anaphylatoxin 25.2 6.3 
Buffer 3.6 4.0 
" All activator concentrations were chosen to give approximately 
20-30% release of "H-serotonin. 
" BSA = bovine serum albumin. 
.. CV A protein = low-molecular-weight cationic protein from cobra 
venom. 
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FIG 7. T op, Desensitization of mast cells to low molecular-weight 
cationic protein cobra venom (CV A) : Mast cells at a concentration of 
5 x 104 cells/ ml, were incubated with 500 ng/ ml of CVA protein and 72 
J.l.M bovine serum albumin for various lengths of time, after which cells 
were centrifuged and resuspended in albumin-free buffer containing 
500 ng/ml of CV A protein; aliquots of cells subsequently were removed 
at various times and assayed for release as described in the caption to 
Fig 2. Bottom., Determination of the half-life of activated mast cells: 
The rate of 3H-serotonin from mast cells by CVA protein measured 
from the slopes of the release curves of Fig 7a has been plotted versus 
the time of incubation of mast cells in the presence of inhibitory 
concentrations of bovine serum albumin; a half-li fe of the activated 
mast cell of approximately 13.5 min has been calculated. 
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concentrations of albumin. Although mast cell degranulation 
proceeded normally in the absence of albumin, no degranulation 
occW"red in the presence of inhibitory concentrations of this 
inhibitor (Fig 8). 
DESENSITIZATION IN THE ABSENCE OF 
INHIBITION 
The above experiments showed that mast cells, in the pres-
ence of an appropriate inhibitor (e.g., one that does not interfere 
with the interaction of stimulus and receptor) can become 
desensitized, or unresponsive, to subsequent stimulus challenge 
without undergoing secretion. We were interested, therefore, in 
examining whether desensitization could be achieved without 
secretion in the absence of inhibitors. For these experiments we 
incubated mast cells with a concentration of stimulus, in this 
case CV A protein, below the tlu'eshold value needed to induce 
secretion and then examined the cells for their subsequent 
response to an optimal concentration of stimulus. Control cells 
were incubated in the absence of stimulus. 
Although mast cells preincubated for 5 min with subthreshold 
concentrations of CV A protein were as able as control cells to 
respond to optimal concentrations of CV A protein, after 30 min 
both the rate and the extent of their secretory response to CV A 
protein were significantly reduced in these cells (Fig 9). This 
was also true at 60 min and 90 min. Thus, we were able to 
achieve at least partial desensitization of mast cells in the 
absence of any inhibitor by using subthreshold concentrations 
of stimulus. 
SUMMARY AND CONCLUSIONS 
We examined the in vitro rat peritoneal mast cell response to 
a number of different non cytotoxic stimuli to probe some of the 
early interactions between the stimulus and the mast cell re-
ceptor that regulate the secretory response. OW" experiments 
demonstrated that an interaction of a noncytotoxic stimulus 
with the mast cell cytoplasmic membrane can be sufficient to 
initiate a secretory response. Stimulus-cell interactions that do 
not lead to secretion can, nevertheless, still profoundly affect 
mast cell responses. It appears from our data that a continued 
interaction between the stimulus and the mast cell is required 
for maintenance of the secretory state. Several lines of evidence 
suggest that different mast cell receptors interact with distinct 
receptors on the cell membrane and initiate different pathways 
leading to secretion, and on the basis of experiments demon-
strating selective inhibition with serum albumin, we h ave con-
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FIG 8. Effect of nonstimulatory concentrations of low molecular-
weight cationic protein cobra venom (CV A) on CV A-protein-initiated 
secretion. An initial dose response profile was performed for determi-
nation of the minimal nonstimulatory concentration of this particulal' 
batch of mast cells. Then 4 ml of mast cells, at a concentration of 1.0 
x lO"/ ml, were incubated for various times at 37°C with either buffer 
or 65 ng/ml of CV A protein. Subsequently 1.0 ml of cells was removed, 
0.5 /lg/ ml of CV A protein was added to each, and 100-/l1 aliquots were 
removed at various times as described in the caption to Fig 2. a, 5 min; 
b, 30 min; c, 60 min; and d, 90 min. 
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FIG 9. Electron micrographs of bovine-serum-albumin-treated and 
low molecular-weight cationic protein cobra venom (CV A)-treated mast 
cells. Cells (2.5 x lO"/ml) were treated with CV A protein (500 ng/ ml) 
for 30 min in the presence (A) or absence (E) of 72 /lM albumin 
(reduced from X 17,500) . 
cluded that at least one biochemical step in the secretion 
pathway subsequent to the interaction of stimulus with the 
mast cell membrane receptor is also not shared by all activator 
molecules. 
Several of t hese experiments, in which the concept and 
consequent terminology of "membrane receptor" have been 
used, were designed to define that specific portion of the mast 
cell membrane with which a particular stimulus interacts. Al-
though such a concept has a rather firm experimental basis in 
the case of the IgE molecule (in fact, several investigators have 
partially isolated and characterized such a receptor [reviewed 
in reference 7]), it is recognized that there is little experimental 
evidence to support the existence of such receptor molecules 
for other noncytotoxic stimuli. Consequently, the possibility of 
nonspecific perturbation of the mast cell membrane by a par-
ticular stimulus cannot be excluded. 
Our results suggest that Compound 48/80 and polymyxin B 
sulfate probably interact with the same site or sites on th e mast 
cell membrane, and we have demonstrated that the site of 
action of polymyxin B is the external mast cell cytoplasmic 
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membrane. On the basis of these experiments, therefore, we 
conclude that the Compound 48/80-cell membrane interaction 
alone is sufficient to initiate secretion; a recently published 
report by Hino, Lau, and Read [11] supports this conclusion. 
These authors demonstrated that, like polymyxin B, Compound 
48/80 covalently bound to an insolubilized matrix also initiates 
histamine release from mast cells. 
We have shown that there are at least 2 distinct pathways by 
which mast cell secretion may be initiated: one, as indicated 
above, that is common to polymyxin B sulfate and Compound 
48/80 and one that is common to CV A protein and C3a ana-
phylatoxin. In addition to indicating 2 distinct pathways, our 
data suggest that some steps subsequent to the initial interac-
tion between the stimulus and its receptor are also distinct. In 
view of the fact that all stimuli eventually result in expelled 
mast cell granules that appear morphologically similar [re-
viewed in reference 1], one might expect a convergence of the 
pathways at some point prior to the actual degranulation signal. 
Because calcium transport into the cell is sufficient to initiate 
degranulation [12], the actual convergence of the different 
pathways leading to activation may occur prior to the calcium 
transport step; this, however, remains to be demonstrated ex-
perimentally. 
The results of experiments demonstrating significant altera-
tions in the mast cell response to a stimulus after preincubation 
with subthreshold concentrations of that stimulus provide fur-
ther support of the concept that stimulus-cell interactions do 
not always lead to secretion. Investigators have shown that 
many cells, including lymphocytes, mast cells, basophils, and 
platelets, require that a stimulus be at least divalent in order to 
revoke a cellular response [reviewed in reference 7]. In both of 
these situations, nonfunctional stimulus-receptor interactions 
interfere with subsequent functional interactions and as a con-
sequence, decrease the capacity of the cell to respond fully. It 
would be interesting to speculate on the potential participation 
such a partial desensitization mechanism might play in chronic 
low-grade inflammation, in which the constant generation of 
low concentrations of potential mast cell activators is never 
sufficient to initiate a mast cell response. 
The experiments described herein further define the initial 
interactions between various stimuli and mast cell receptors 
leading to a secretory response. However, because of the re-
markable similarity that exists between the mast cell and other 
inflammatory mediator cells in their noncytotoxic response to 
stimuli [reviewed in reference 7], these experiments may well 
provide information on generalized mechanisms of cellular re-
sponses to external stimuli. 
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